Serina Therapeutics, Inc. Fair Value of Assets Acquired
Serina Therapeutics, Inc. (SER) reported Fair Value of Assets Acquired of $115.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-25.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:FairValueOfAssetsAcquired · last filed 2026-03-25
- Serina Therapeutics, Inc. fair value of assets acquired for the quarter ending 2024-12-31 was $0.00, a 100.00% decline year-over-year.
- Serina Therapeutics, Inc. fair value of assets acquired for the quarter ending 2023-12-31 was $83.00K.
- Serina Therapeutics, Inc. fair value of assets acquired for the quarter ending 2023-09-30 was $175.00K.
- Serina Therapeutics, Inc. fair value of assets acquired for the quarter ending 2023-06-30 was $0.00.
- Serina Therapeutics, Inc. fair value of assets acquired for fiscal 2025 was $115.00K.
- Serina Therapeutics, Inc. fair value of assets acquired for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Serina Therapeutics, Inc. fair value of assets acquired for fiscal 2023 was $755.00K.
| Period end | Fair Value of Assets Acquired 3 month | Fair Value of Assets Acquired 6 month | Fair Value of Assets Acquired 9 month | Fair Value of Assets Acquired 12 month |
|---|---|---|---|---|
| 2025-12-31 | $115.00K 10-K · filed 2026-03-25 | |||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $0.00 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $258.00K derived: sum of 2 quarters · filed 2025-03-24 | $258.00K derived: sum of 3 quarters · filed 2025-03-24 | $755.00K 10-K · filed 2025-03-24 |
| 2023-09-30 | $175.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $175.00K derived: sum of 2 quarters · filed 2024-11-12 | $672.00K 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $497.00K 10-Q · filed 2024-08-09 | ||
| 2023-03-31 | $497.00K 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| TALPHERA, INC. (TLPH) | United States | $0.060B |